Here’s How AI Could Bring Better Fruit to Your Table
Researchers at the University of Florida envision a quicker method: exploring the natural variations in plant genetics using artificial intelligence. The applications extend far beyond blueberries, a growing sector of Florida’s $182.6 billion agriculture industry. Their brainchild, the AI Connoisseur, would not only give Florida farms an edge, but make healthy food more palatable to more people, bringing varieties with heirloom-quality flavor within everyone’s reach. All they’d have to do is teach a computer to taste.
This Geneticist’s Goal: Cure the Disease That Runs in His Family
Dr. Eric Wang has always been interested in understanding how biological systems function, but in part entered this field and joined the team at UF because he has family members affected by myotonic dystrophy. He is personally motivated to better understand DM and related diseases, and to find treatments.
UF Researchers Find New Sugar Substitutes in Citrus That Could Change Food and Beverage Industry
Finding natural, non-caloric sugar substitutes is desirable but challenging. However, researchers at the University of Florida Institute of Food and Agricultural Sciences have made a breakthrough — discovering new, natural sweeteners in citrus for the first time.
New HiPerGator Simulations “Solve Mother Nature” To Address Real-World Problems
In one of the most intensive uses yet of the University of Florida’s HiPerGator supercomputer, UF engineers have faithfully reproduced the turbulence and complexity of hot air rising along a wall — a previously impossible simulation with applications in home fire safety and heating and cooling.
UF Health Researcher Aims To Create AI Algorithm To Help Map Human Body’s Cells
Recently hired UF College of Medicine faculty member Pinaki Sarder, Ph.D., is leading a project where researchers at UF Health are developing an artificial intelligence algorithm to be used by scientists around the nation who are mapping out the entire human body at the single-cell level.
Lacerta and Prevail, a Wholly Owned Subsidiary of Lilly, Sign Agreement To Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company. The collaboration will focus on the discovery and development of novel AAV capsids for CNS diseases.
UF Pediatric Oncologist Awarded v Foundation Grant for Pediatric Osteosarcoma Study
University of Florida Health pediatric oncologist John A. Ligon, M.D., has been awarded a $600,000 grant from the V Foundation for Cancer Research to study a personalized immunotherapy vaccine to treat relapsed pediatric osteosarcoma.
UF Researchers Find Genes Responsible for Several Flavor Compounds in Strawberries
In their quest to improve strawberry flavor, University of Florida scientists have found the genes behind several aromatic chemicals that enhance the fruit’s taste.
Three UF Faculty Elected to Academy of Science, Engineering, and Medicine of Florida
Three University of Florida faculty will be inducted into the Academy of Science, Engineering, and Medicine of Florida in 2022. The academy, which recognizes the work of individuals of the State of Florida who have made major achievements in science, engineering, and medicine, will present awards to the following faculty during its annual meeting on November 5-6 in Orlando.
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, announced that it has purchased a $1.0 million convertible note from UF startup Structured Monitoring Products, Inc. (SMP), makers of the VetGuardianTM wireless remote pet monitoring platform, and in connection therewith has acquired the option to act as a sales agent for SMP's platform. Under the terms of the agreement, Zomedica will also have the option to acquire the VetGuardian product line for use in Animal Health.
